Travere Therapeutics Inc (NASDAQ:TVTX)
| 21.71 Delayed Data As of 3:59pm ET |  -0.82 / -3.64%Today’s Change | 17.97 Today|||52-Week Range 30.35 | +3.23% Year-to-Date |
Latest TVTX News | Press Releases
| The Nasdaq Is Rebounding: 2 Supercharged Growth Stocks to Buy in February Feb 01 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 22.53 |
| Today’s open | 22.33 |
| Day’s range | 21.68 - 22.54 |
| Volume | 24,131 |
| Average volume (3 months) | 886,406 |
| Market cap | $1.4B |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | +15.55% |
| Earnings growth (this year) | -46.74% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +14.71% |
| P/E ratio | NM |
| Price/Sales | 8.16 |
| Price/Book | 4.48 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DVAXDynavax Technologies... | -0.21 | -1.72% |
| RCUSArcus Biosciences In... | -0.66 | -3.12% |
| ---- | ||
| AUPHAurinia Pharmaceutic... | -0.25 | -2.74% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | February 28, 2023 |
| EPS forecast (this quarter) | -$1.07 |
| Annual revenue (last year) | $227.5M |
| Annual profit (last year) | -$180.1M |
| Net profit margin | -79.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
